Patents by Inventor Roger Peters

Roger Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6924990
    Abstract: A switch mode power supply and its start-up circuit produce a controlled output voltage from an input voltage. A power supply control circuit is powered by the output voltage and is responsive to the output voltage to control the power supply. The control circuit responds to differences between a fraction of the output voltage and a reference voltage to control the start-up circuit. This control is inhibited at low values of the output voltage to ensure that the power supply starts up correctly despite the reference voltage being indefinite or unstable at such low values of the output voltage.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: August 2, 2005
    Assignee: Potentia Semiconductor, Inc.
    Inventors: Roger Peter Colbeck, Rajko Duvnjak
  • Patent number: 6852360
    Abstract: A knitted screen cloth fabric including a polymer coated, fiber-reinforced, flexible, foil-like web and method for making same are disclosed, the web including a lattice material of filaments and a polyester binding thread.
    Type: Grant
    Filed: February 25, 2004
    Date of Patent: February 8, 2005
    Assignee: Saint-Gobain Technical Fabrics Canada, Ltd.
    Inventors: John Frederick Porter, Roger Peter Lewington
  • Patent number: 6850048
    Abstract: A power supply controller controls power supplies for power-up and/or shut-down in a desired sequence. An input voltage for the power supplies powers, and is monitored by, a first control unit having outputs for enabling the power supplies. A second control unit monitors output voltages of the power supplies, and an isolating signal coupler couples signals in both directions between the first and second control units. The second control unit is powered in an isolated manner from the input voltage, conveniently via a transformer constituting the signal coupler. The control units together respond to the monitored voltages for enabling the power supplies in accordance with the desired sequence, information for which can be stored in a non-volatile store. The second control unit can also include enable outputs isolated from the input voltage, and trim outputs for adjusting the monitored voltages.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: February 1, 2005
    Assignee: Potentia Semiconductor, Inc.
    Inventors: Raymond Kenneth Orr, Yan-Fei Liu, Roger Peter Colbeck, David Alan Brown, Hartley Fred Horwitz
  • Publication number: 20040218408
    Abstract: A switch mode power supply and its start-up circuit produce a controlled output voltage from an input voltage. A power supply control circuit is powered by the output voltage and is responsive to the output voltage to control the power supply. The control circuit responds to differences between a fraction of the output voltage and a reference voltage to control the start-up circuit. This control is inhibited at low values of the output voltage to ensure that the power supply starts up correctly despite the reference voltage being indefinite or unstable at such low values of the output voltage.
    Type: Application
    Filed: May 2, 2003
    Publication date: November 4, 2004
    Inventors: Roger Peter Colbeck, Rajko Duvnjak
  • Publication number: 20040217749
    Abstract: A power supply controller controls power supplies for power-up and/or shut-down in a desired sequence. An input voltage for the power supplies powers, and is monitored by, a first control unit having outputs for enabling the power supplies. A second control unit monitors output voltages of the power supplies, and an isolating signal coupler couples signals in both directions between the first and second control units. The second control unit is powered in an isolated manner from the input voltage, conveniently via a transformer constituting the signal coupler. The control units together respond to the monitored voltages for enabling the power supplies in accordance with the desired sequence, information for which can be stored in a non-volatile store. The second control unit can also include enable outputs isolated from the input voltage, and trim outputs for adjusting the monitored voltages.
    Type: Application
    Filed: May 2, 2003
    Publication date: November 4, 2004
    Inventors: Raymond Kenneth Orr, Yan-Fei Liu, Roger Peter Colbeck, David Alan Brown, Hartley Fred Horwitz
  • Publication number: 20040217785
    Abstract: A reset circuit produces a composite reset signal, in dependence upon a supply voltage, from reset signals produced by three reset units. A first unit produces its reset signal in dependence upon a precise voltage comparison. A second unit, operable at lower values of the supply voltage than the first unit, produces its reset signal in dependence upon the forward voltage drop of a diode. A third unit produces its reset signal in dependence upon charging of a capacitor from the supply voltage via a resistance, to maintain the composite reset signal for at least a predetermined period.
    Type: Application
    Filed: May 2, 2003
    Publication date: November 4, 2004
    Inventors: Roger Peter Colbeck, Ognjen Brkic
  • Publication number: 20040166750
    Abstract: A knitted screen cloth fabric including a polymer coated, fiber-reinforced, flexible, foil-like web and method for making same are disclosed, the web including a lattice material of filaments and a polyester binding thread.
    Type: Application
    Filed: February 25, 2004
    Publication date: August 26, 2004
    Inventors: John Frederick Porter, Roger Peter Lewington
  • Patent number: 6716774
    Abstract: A knitted screen cloth fabric including a polymer coated, fiber-reinforced, flexible, foil-like web and method for making same are disclosed, the web including a lattice material of filaments and a polyester binding thread.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: April 6, 2004
    Assignee: Saint-Gobain Technical Fabrics Canada, Ltd.
    Inventors: John Frederick Porter, Roger Peter Lewington
  • Patent number: 6673789
    Abstract: Compounds of formula (I): or a pharmaceutically acceptable salt thereof, or solvate of either entity, wherein R4 is a guanidinyl moiety and the other substituents are as defined in the text, are urokinase inhibitors.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: January 6, 2004
    Assignee: Pfizer, Inc.
    Inventors: Roger Peter Dickinson, Christopher Gordon Barber
  • Publication number: 20030203914
    Abstract: Compounds of formula (I):- 1
    Type: Application
    Filed: March 12, 2003
    Publication date: October 30, 2003
    Inventors: Roger Peter Dickinson, Christopher Gordon Barber
  • Patent number: 6583162
    Abstract: Compounds of formula (I): or a pharmaceutically acceptable salt thereof, or solvate of either entity, wherein R4 is a guanidinyl moiety and the other substituents are as defined in the text, are urokinase inhibitors.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: June 24, 2003
    Assignee: Warner-Lambert Company
    Inventors: Roger Peter Dickinson, Christopher Gordon Barber
  • Publication number: 20020137410
    Abstract: A knitted screen cloth fabric including a polymer coated, fiber-reinforced, flexible, foil- like web and method for making same are disclosed, the web including a lattice material of filaments and a polyester binding thread.
    Type: Application
    Filed: December 19, 2001
    Publication date: September 26, 2002
    Inventors: John Frederick Porter, Roger Peter Lewington
  • Patent number: 6384070
    Abstract: Compounds of formula (I), and their pharmaceutically acceptable derivatives, wherein R1 and R2 are optional substituents and independently represent C1-6 alkyl, C2-6 alkenyl, optionally substituted by CO2H or CO2(C1-6 alkyl), C2-6 alkynyl, halogen, C1-3 perfluoroalkyl, (CH2)mAr1, (CH2)mHet1, (CH2)mCONR7R8, (CH2)mCO2R8, O(CH2)qCO2R8, (CH2)mCOR8, (CH2)mOR8, O(CH2)pOR8, (CH2)mNR7R8, CO2(CH2)qNR7R8, (CH2)mCN, S(O)nR8, SO2NR7R8, CONH(CH2)mAr1 or CONH(CH2)mHet1; R3 represents H, C1-6 alkyl, (CH2)pNR9R10, SO2R10, SO2NR9R10, (CH2)mCO2R10, C2-6 alkenyl, C2-6 alkynyl, (CH2)mCONR9R10, (CH2)mCO2R10, (CH2)pCN, (CH2)pR10 or (CH2)pOR10; R4 represents H or C1-6 alkyl; R5 represents H or OH; R6 represents phenyl optionally fused to a heterocyclic ring, the group as a whole being optionally substituted; R7-10 are fully defined herein and may independently represent Ar2 or Het2; Z represents CO2H, CONH(tetrazol-5-yl), CONHSO2O(C1-4 alkyl), CO2Ar3, CO2(C1-6 alkyl), tetrazol-5-yl, CONHSO2Ar3, CONHSO2(CH2)qAr3 or
    Type: Grant
    Filed: January 9, 2001
    Date of Patent: May 7, 2002
    Assignee: Pfizer Inc.
    Inventors: David James Rawson, Kevin Neil Dack, Roger Peter Dickinson, Kim James
  • Patent number: 6350907
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, or solvates of either entity, wherein the substituents have the values described herein, are useful as matrix metalloprotease (MMP) inhibitors
    Type: Grant
    Filed: April 11, 2000
    Date of Patent: February 26, 2002
    Assignee: Pfizer Inc
    Inventors: Michael Jonathan Fray, Roger Peter Dickinson, Kevin Neil Dack
  • Patent number: 6306852
    Abstract: Compounds of formula (I), and their pharmaceutically acceptable derivatives, wherein R1 and R2 are optional substituents and independently represent C1-6 alkyl, C2-6 alkenyl, optionally substituted by CO2H or CO2(C1-6 alkyl), C2-6 alkynyl, halogen, C1-3 perfluoroalkyl, (CH2)mAr1, (CH2)mHet1, (CH2)mCONR7R8, (CH2)mCO2R8, O(CH2)qCO2R8, (CH2)mCOR8, (CH2)mOR8, O(CH2)pOR8, (CH2)mNR7R8, CO2(CH2)qNR7R8, (CH2)mCN, S(O)nR8, SO2NR7R8, CONH(CH2)mAr1 or CONH(CH2)mHet1; R3 represents H, C1-6 alkyl, (CH2)pNR9R10, SO2R10, SO2NR9R10, (CH2)mCO2R10, C2-6 alkenyl, C2-6 alkynyl, (CH2)mCONR9R10, (CH2)mCO2R10, (CH2)pCN, (CH2)pR10 or (CH2)pOR10; R4 represents H or C1-6 alkyl; R5 represents H or OH; R6 represents phenyl optionally fused to a herterocyclic ring, the group as a whole being optionally substituted; R7-10 are fully defined herein and may independently represent Ar2 or Het2; Z represents CO2H, CONH(tetrazol-5-yl), CONHSO2O(C1-4 alkyl), CO2Ar3, CO2(C1-6 alkyl), tetrazol-5-yl, CONHSO2Ar3, CONHSO2(CH2)qAr3 o
    Type: Grant
    Filed: April 24, 2000
    Date of Patent: October 23, 2001
    Assignee: Pfizer Inc.
    Inventors: David James Rawson, Kevin Neil Dack, Roger Peter Dickinson, Kim James
  • Publication number: 20010014677
    Abstract: 1
    Type: Application
    Filed: January 9, 2001
    Publication date: August 16, 2001
    Inventors: David James Rawson, Kevin Neil Dack, Roger Peter Dickinson, Kim James
  • Patent number: 6248738
    Abstract: Compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N═C(NH2)2 or NHC(═NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: June 19, 2001
    Assignee: Pfizer Inc.
    Inventors: Roger Peter Dickinson, Christopher Gordon Barber, Paul Vincent Fish
  • Patent number: 6211223
    Abstract: The invention provides S-(+)-3-{1-(1,3-benzodioxol-5-yl)-2-[(2-methoxy-4-methylphenyl)sulfonylamino]-2-oxoethyl}-1-methyl-1H-indole-6-carboxylic acid, which is substantially free from its (R)-(−)-enantiomer, and pharmaceutically acceptable derivatives thereof. The compounds are useful in the treatment of inter alia acute renal failure, restenosis and pulmonary hypertension.
    Type: Grant
    Filed: April 18, 2000
    Date of Patent: April 3, 2001
    Assignee: Pfizer Inc.
    Inventors: Stephen Challenger, Kevin Neil Dack, Andrew Michael Derrick, Roger Peter Dickinson, David Ellis, Yousef Hajikarimian, Kim James, David James Rawson
  • Patent number: 6136843
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: October 24, 2000
    Assignee: Pfizer Inc
    Inventors: David James Rawson, Kevin Neil Dack, Roger Peter Dickinson, Kim James
  • Patent number: 6093731
    Abstract: Isoquinolinylguanidine compounds of formula (I): ##STR1## wherein the substituents are as defined herein, and salts thereof, are disclosed as urokinase inhibitors.
    Type: Grant
    Filed: July 22, 1999
    Date of Patent: July 25, 2000
    Inventors: Roger Peter Dickinson, Paul Vincent Fish, Christopher Gordon Barber